Jacquelyn Awigena Cook
About Jacquelyn Awigena Cook
Jacquelyn Awigena Cook is the Director of Global Regulatory Policy & Intelligence at Bristol Myers Squibb, with over 15 years of experience in regulatory policy and pharmacovigilance.
Title: Director, Global Regulatory Policy & Intelligence
Jacquelyn Awigena Cook currently holds the position of Director, Global Regulatory Policy & Intelligence at Bristol Myers Squibb in Uxbridge, United Kingdom. In this role, she oversees the development and implementation of regulatory policies and provides strategic intelligence to support the company's global regulatory affairs.
Work Experience at Celgene
From 2016 to 2021, Jacquelyn Awigena Cook worked at Celgene, beginning as a Senior Manager in Regulatory Intelligence & Policy before advancing to Associate Director, EMEA Regulatory Intelligence & Policy. During her tenure, she played a key role in shaping regulatory policies within the European, Middle Eastern, and African markets.
Work Experience at Johnson & Johnson
Jacquelyn Awigena Cook spent a significant portion of her career at Johnson & Johnson, starting as a Health Policy Intern in 2007 and progressing through multiple positions including Program Manager in the Translational Pharmacovigilance Team and Associate Director, Head of Pharmacovigilance Policy. She worked at the company until 2016, gaining extensive experience in pharmacovigilance and public policy.
Education and Expertise
Jacquelyn Awigena Cook has a diverse educational background. She earned a Graduate Diploma in Law (GDL) from The University of Law, an MSc in Biomedicine, Bioscience & Society from The London School of Economics and Political Science (LSE), and a BS in Cell Biology/Biochemistry from Bucknell University. This combination of scientific and legal expertise equips her with a comprehensive approach to regulatory policy and pharmacovigilance.
Career Highlights and Expertise
With over 15 years of experience in regulatory policy and pharmacovigilance, Jacquelyn Awigena Cook has held multiple leadership roles, demonstrating a consistent track record of advancing in her field. She has contributed to the development of biopharmaceutical regulations and worked on projects that bridge clinical research and regulatory compliance. Her multidisciplinary background supports her work in creating and influencing global regulatory policies.